13F Portfolios

Alpha Wave Global, LP: LENZ THERAPEUTICS INC (LENZ): Quarterly 13F Position History

As of Q1 2026, Alpha Wave Global, LP reported 3,612,211 shares of LENZ THERAPEUTICS INC (LENZ), worth $33.1M and representing 4.2% of its 13F equity book. The position first appeared in Q1 2024 and has been disclosed across 9 13F-HR filings in Pactolio's tracked window.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 9 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 3,612,211 0 $33.1M 4.2% $9.2
Q4 2025 3,612,211 0 $57.8M 7.1% $16.0
Q3 2025 3,612,211 0 $168.3M 17.0% $46.6
Q2 2025 3,612,211 0 $105.9M 11.4% $29.3
Q1 2025 3,612,211 0 $92.9M 41.4% $25.7
Q4 2024 3,612,211 0 $104.3M 48.3% $28.9
Q3 2024 3,612,211 0 $85.8M 26.6% $23.7
Q2 2024 3,612,211 0 $62.5M 20.9% $17.3
Q1 2024 3,612,211 $80.7M 28.7% $22.3

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did Alpha Wave Global, LP first disclose a LENZ position in 13F-HR filings?

Alpha Wave Global, LP first reported LENZ THERAPEUTICS INC (LENZ) on its 13F-HR filing for the period ending 2024-03-31 (Q1 2024). The position has appeared on 9 reported quarters within Pactolio's tracked window.

What was Alpha Wave Global, LP's most recent quarter-over-quarter share-count change in LENZ?

Alpha Wave Global, LP held the same 3,612,211 shares of LENZ between Q4 2025 and Q1 2026 — the reported share count was unchanged quarter-over-quarter.

Does the implied price-per-share represent Alpha Wave Global, LP's cost basis in LENZ?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.